1 completed, 1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Mirena®: new trials by email Literature Review of Mirena® trials Research Report on Mirena®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC Progesterone, Mirena®, GnRH agonist - Endometrial Cancer, Atypical Endometrial Hyperplasia | Phase 2 / Phase 3 | Recruiting | West China Second University Hospital | 224 | 2018-04-01 | 2021-09-13 |
| Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer Metformin, Mirena® - Endometrial Cancer | Phase 2 | Unknown | Chang Gung Memorial Hospital | 120 | 2016-03-01 | 2016-12-13 |
| Long-Acting Reversible Contraception DMPA, oral contraceptives, Implanon® - Contraception | Phase 4 | Completed | FHI 360 | 916 | 2011-12-01 | 2018-02-28 |
Endometrial Neoplasms (2) · Endometrial Hyperplasia (1)
Chang Gung Memorial Hospital (1) · FHI 360 (1) · West China Second University Hospital (1)
China (1) · United States (1)